Dave Burnett, Ph.D., RRT, AE-C
Interim Associate Dean for Faculty Practice and Community Partnership
Chair, Department of Respiratory Care Education
KU Department of Respiratory Care Education
Dave Burnett, Ph.D., RRT, AE-C, joined the school's faculty in 2012 and serves as department chair and assistant professor. Burnett's undergraduate training was in respiratory therapy and health care management. He received his master’s degree in exercise physiology from the University of Central Missouri and his doctorate in rehabilitation science from the University of Kansas.
On October 1, 2018, Burnett was appointed interim associate dean for faculty practice and community partnership for the School of Health Professions.
Burnett's research is focused on preventing severity of primary disease processes and their potential co-morbid conditions. In particular he focuses on prevention and treatment of asthma. He also is part of a multidisciplinary team investigating the effects of exercise and nutrition on multiple organ systems in cystic fibrosis.
Having worked clinically as a registered respiratory therapist, Burnett has more than 20 years of experience in hospital, physician office, and rehabilitative settings.
Currently Burnett is principal investigator on two asthma projects: exercise-induced bronchoconstriction (EIB) and community-based asthma self-management. Burnett is in collaboration with university members of the NCAA and NAIA to study the prevalence of EIB and to help develop a screening program for identifying those at risk for the condition.
In addition, Burnett partners with asthma stakeholders including physicians, school nurses, telehealth providers, and hospitals to help improve the health outcomes of asthma patients and reduce the financial burden chronic respiratory conditions can have when symptoms are not managed properly by patients. Burnett is co-founder and director of the KU Asthma Center.
Another of Burnett's projects involves assessing the impact interventions, including exercise and nutrition, have on multiple organ systems in patients with cystic fibrosis. Since improved cardiopulmonary fitness is associated with increased survival, he aims to measure the impact of improved pulmonary, cardiac, and skeletal muscle function in those suffering from the disease.